Giphy

(Corrects first sentence to say bill will be considered next week and second sentence to say Schrader is a Democrat.)

The Energy and Commerce committee will take up a bipartisan bill next week to encourage generic drug development and increase market competition, Chairman Greg Walden announced at a hearing Thursday morning.

The bill by Reps. Gus Bilirakis, a Republican, and Kurt Schrader, a Democrat, would require the Food and Drug Administration to priortize and expedite the review of generic applications for drugs that are in short supply or don't have much market competition. The goal is to get at "bad actors" raising the price of old, off-patent drugs. The bill also "increases transparency" around the generic backlog at the FDA, Walden said, although he didn't give any details.

Walden, in prepared remarks, also fired a warning shot at companies like Mylan and Turing, which have bought old drugs and hiked prices: "For those in industry who think it's OK to corner a market, drive up prices and rip off consumers, know that your days are numbered."

Go deeper

Obama: Trump is "jealous of COVID's media coverage"

Former President Barack Obama launched a blistering attack on President Trump while campaigning for Joe Biden in Orlando on Tuesday, criticizing Trump for complaining about the pandemic as cases soar and joking that he's "jealous of COVID's media coverage."

Driving the news: Trump has baselessly accused the news media of only focusing on covering the coronavirus pandemic — which has killed over 226,000 Americans so far and is surging across the country once again — as a way to deter people from voting on Election Day and distract from other issues.

Wisconsin Democrats: Don't return absentee ballots by mail

Signs for Joe Biden are seen outside a home in Coon Valle, Wisconsin, on Oct. 3. Photo by KEREM YUCEL via Getty

Wisconsin Democrats are urging voters to return absentee ballots to election clerks’ offices or drop boxes after a Supreme Court decision on Monday prevented the state from extending its deadline for counting absentee ballots, The New York Times reports.

Why it matters: 1,344,535 of the 1,706,771 Wisconsin voters who requested absentee ballots have returned them, according to the Times. The remaining 366,236 could prove critical in the battleground state, where President Trump won by a thin margin in 2016.

Dan Primack, author of Pro Rata
Updated 2 hours ago - Economy & Business

Winter coronavirus threat spurs new surge of startup activity

Illustration: Sarah Grillo/Axios

U.S. coronavirus cases and hospitalizations are surging, with cold weather arriving before even the best-case scenario for a widely distributed vaccine. Now we're also beginning to see an increase in coronavirus-related startup funding, focused on both testing and pharma.

Driving the news: Gauss, a Silicon Valley computer vision startup focused on health care, tells Axios that it's raised $10 million to accelerate development and commercialization of an at-home rapid antigen test for COVID-19.